EUVIMEDObjevte EUVIMED
Crossref

N-cadherin-triggered myosin II inactivation provides tumor cells with a mechanical cell competition advantage and chemotherapy resistance

Zhenlin Dai, Shengkai Chen, Jianbo Shi, Mengyu Rui, Qin Xu

Developmental Cell · 2025

DOI: 10.1016/j.devcel.2025.01.020 ↗

At a glance

Journal article in Developmental Cell, 2025. Written by Zhenlin Dai and 4 co-authors. Institution: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200…. Major MEDLINE topics: Cadherins, Myosin Type II, Drug Resistance, Neoplasm. Cited 1 times so far (Crossref); 59 references. Funded by: Shanghai Lingjun Program, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The concept that mechanical cell competition may contribute to tumor cell expansion has been widely discussed. However, whether this process could occur during natural tumor progression, as well as its underlying mechanisms and clinical implications, remains largely unknown. In this study, we observed that self-seeded tumor cell lines of human oral cancer, SCC9- and SCC25-seeded cells, exhibited a mechanical competitive advantage, outcompeted neighboring cells, and became "winner" cells. Mechanical compression-induced calcium influx activates myosin II in "loser" cells, leading to apoptotic nuclear breakdown and subsequent clearance. N-cadherin/Rac1/PAK1/myosin light-chain kinase (MLCK)-controlled myosin II inactivation endows cells with resistance to mechanical stress and superior cellular flexibility, thus providing a cell competition advantage to self-seeded cells. The activation of the N-cadherin/Rac1/PAK1/MLCK/myosin II signaling axis is associated with drug resistance. Together, these results suggest that N-cadherin/Rac1/PAK1/MLCK signaling-induced myosin II inactivation enables tumor cells to acquire resistance to mechanical stress and a competitive advantage. Our study also provides insights into drug resistance from a stress-sensitivity perspective.

Subjects

MeSH terms (MEDLINE)

CadherinsMyosin Type IIDrug Resistance, NeoplasmHumansCell Line, Tumorp21-Activated Kinasesrac1 GTP-Binding ProteinSignal TransductionMyosin-Light-Chain KinaseApoptosisStress, MechanicalAntigens, CD

Author keywords

cellular flexibilitydrug resistancemechanical cell competitionself-seeding

Substances

CadherinsMyosin Type IIp21-Activated Kinasesrac1 GTP-Binding ProteinMyosin-Light-Chain KinaseRAC1 protein, humanPAK1 protein, humanCDH2 protein, humanAntigens, CD

Authors and institutions

  • Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, China; Shanghai Key Laboratory of Stomatology & Shanghai Research…

Funding

  • Shanghai Lingjun Program
  • National Natural Science Foundation of China

Cite

APA

Dai, Z., Chen, S., Shi, J., Rui, M., & Xu, Q. (2025). N-cadherin-triggered myosin II inactivation provides tumor cells with a mechanical cell competition advantage and chemotherapy resistance. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.01.020

Vancouver

Dai Z, Chen S, Shi J, Rui M, Xu Q. N-cadherin-triggered myosin II inactivation provides tumor cells with a mechanical cell competition advantage and chemotherapy resistance. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.01.020

BibTeX
@article{Dai2025,
  author = {Dai, Zhenlin and Chen, Shengkai and Shi, Jianbo and Rui, Mengyu and Xu, Qin},
  title = {N-cadherin-triggered myosin II inactivation provides tumor cells with a mechanical cell competition advantage and chemotherapy resistance},
  journal = {Developmental Cell},
  year = {2025},
  doi = {10.1016/j.devcel.2025.01.020}
}
Start for free →